ArticleAesthetic surgery journal. Open forum2026
Determining the Position, Morphology, and Location of the Depressor Anguli Muscle Through Ultrasound in the Caucasian Population.
Article in Aesthetic surgery journal. Open forum, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The depressor anguli oris (DAO) muscle plays a key role in expressing sadness by lowering the oral commissures. Botulinum toxin (BT) is frequently used to weaken DAO hyperactivity, but results remain inconsistent because of reliance on cadaveric studies and surface landmarks, often derived from Asian populations. Ethnic anatomical variability may compromise injection accuracy. Objectives: The aim of this study was to evaluate DAO morphology in Caucasian patients using high-frequency ultrasound. Methods: A total of 290 Caucasian patients seeking DAO treatment with BT were assessed. Exclusion criteria were neuromuscular disease or previous BT in the area. Ultrasound evaluated the DAO position relative to the mid-pupillary line, depth from the skin, and overlap with adjacent muscles. Results: DAO localization showed significant variability: 20.2% were aligned with the classical mid-pupillary landmark and 79.8% exhibited lateral displacement (2-5 mm). Mean DAO depth was 3.1 mm, greater in overweight/obese patients ( Conclusions: DAO topography in Caucasians differs significantly from that reported in standard references. Blind injections may reduce the treatment efficacy and increase the side-effect rate. High-frequency ultrasound enables precise DAO mapping, individualized injection planning, and improved treatment predictability. Preinjection ultrasound should be considered for safe and effective DAO neuromodulation. Level of Evidence 3 Diagnostic:
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.